Skip to main content

Table 1 Patient demographics

From: Safety and efficacy of thermo-expandable metallic stent in ureteral stricture following gynecological malignancy surgery and radiotherapy: a single center experience with 33 cases

Variable

 

N

Total case

 

27

Age (y)

 

49.86 ± 10.71

Sex (m/f)

 

F 27

Height(cm)

 

157.79 ± 5.13

Weight (Kg)

 

65.68 ± 9.29

BMI

 

26.34 ± 3.23

Primary disease (n)

  
 

cervical carcinoma

19(70.37%)

 

ovarian cancer

2(7.40%)

 

endometrial carcinoma

6(22.23%)

Adjuvant therapy for the primary disease (n)

  
 

Combined with RT and chemoradiotherapy

24(88.89%)

 

Radiotherapy only

3(11.11%)

Prior treatment for US (n)

  
 

nephrostomy

7

 

double-J

26

 

allium stent

5

Interval time between therapy for hydronephrosis and RT (y)

 

5.35 ± 4.14

  1. US, Ureteral stricture; BMI, Body mass index